drugset / Trial / NCT04305158

Colonoscopy Using Nitrous Oxide- A Pilot Study in the USA

NCT04305158

Phase 0 Completed 200 enrolled University of Arkansas
RandomizedCrossoverSingle-blindTreatment

Summary

Colon cancer is the second most common cancer in men and the third most common cancer in women worldwide. The clinical objectives of administering sedation for GI endoscopy are to relieve patient anxiety and discomfort and to improve the outcome of the examination. Use of N2O could potentially provide an alternate safe and cheap option for patients who do not prefer IV sedation for colonoscopy

Timeline

Start
2022-03-28
Primary completion
2023-08-10
Completion
2023-08-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitrous Oxide Other / unclassified Inhaled

Indications

No indication recorded.